P

Inventor

ZAUDERER MAURICE

US40 patents
⚠️ This page may combine multiple inventors who share the name “ZAUDERER MAURICE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VACCINEX INC

25 patents
US9828435B2Nov 28, 2017

Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4D to increase tumor infiltrating leukocyte frequency

VACCINEX INC22 citations94
US9243068B2Jan 26, 2016

Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastases

VACCINEX INC25 citations94
US7919594B2Apr 5, 2011

Human anti-CD100 antibodies

VACCINEX INC55 citations94
US9090709B2Jul 28, 2015

Anti-SEMA4D antibodies and epitopes

VACCINEX INC18 citations92
US9598495B2Mar 21, 2017

Use of semaphorin-4D binding molecules for treating neurodegenerative disorders

VACCINEX INC16 citations91
US9249227B2Feb 2, 2016

Use of semaphorin-4D binding molecules for treating neurodegenerative disorders

VACCINEX INC18 citations91
US9890213B2Feb 13, 2018

Methods for the treatment of B cell-mediated inflammatory diseases

VACCINEX INC10 citations84
US9790271B2Oct 17, 2017

Methods for increasing immunoglobulin A levels

VACCINEX INC10 citations84
US9512224B2Dec 6, 2016

Use of semaphorin-4D binding molecules for treatment of atherosclerosis

VACCINEX INC11 citations84
US10111950B2Oct 30, 2018

Modified glycolipids and methods of making and using the same

VACCINEX INC5 citations83
US9371352B2Jun 21, 2016

Modified glycolipids and methods of making and using the same

VACCINEX INC10 citations83
US9708601B2Jul 18, 2017

Fusion proteins to facilitate selection of cells infected with specific immunoglobulin gene recombinant vaccinia virus

VACCINEX INC7 citations80
US10800853B2Oct 13, 2020

Use of semaphorin-4D binding molecules for treating neurodegenerative disorders

VACCINEX INC1 citations72
US10385136B2Aug 20, 2019

Use of semaphorin-4D binding molecules for treating neurodegenerative disorders

VACCINEX INC3 citations72
US11078295B2Aug 3, 2021

Use of semaphorin-4D inhibitory molecules with an immune modulating therapy to inhibit tumor growth and metastases

VACCINEX INC2 citations71
US11427634B2Aug 30, 2022

Human anti-semaphorin 4D antibody

VACCINEX INC4 citations70
US9701958B2Jul 11, 2017

Method for selecting polynucleotides encoding antigen-specific immunoglobulin subunits

VACCINEX INC4 citations69
US11597765B2Mar 7, 2023

Use of semaphorin-4D binding molecules for the treatment of Rett syndrome

VACCINEX INC2 citations67
US12070500B2Aug 27, 2024

Use of semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastasis

VACCINEX INC0 citations62
US11534488B2Dec 27, 2022

Use of semaphorin-4D binding molecules for modulation of blood brain barrier permeability

VACCINEX INC1 citations62
US12006365B2Jun 11, 2024

Human anti-semaphorin 4D antibody

VACCINEX INC1 citations59
US11572408B2Feb 7, 2023

Treatment of cancer with a semaphorin-4D antibody in combination with an epigenetic modulating agent

VACCINEX INC0 citations58
US10526414B2Jan 7, 2020

Use of anti-semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastases

VACCINEX INC0 citations52
US10494440B2Dec 3, 2019

Use of semaphorin-4D binding molecules to promote neurogenesis following stroke

VACCINEX INC0 citations52
US10662422B2May 26, 2020

Method for selecting polynucleotides encoding antigen-specific immunoglobulin subunit

VACCINEX INC0 citations46

UNIV ROCHESTER

12 patents

ZAUDERER MAURICE

2 patents

ROBERT BRUNO

1 patent